首页 > 市场调查报告书 > 製药

糖尿病

市场调查报告书

商品编码

1672637

糖尿病视网膜病变市场：依疾病类型、治疗类型、给药途径、最终用途、通路及地区划分

Diabetic Retinopathy Market, By Disease Type, By Treatment Type, By Route of Administration, By End User, By Distribution Channel, By Geography

出版日期: 2025年02月07日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球糖尿病视网膜病变市场规模估计为 99.1 亿美元，预计到 2032 年将达到 154 亿美元，2025 年至 2032 年的复合年增长率为 6.5%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	99.1亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	6.50％	2032 年价值预测	154亿美元

数字。 2025 年糖尿病视网膜病变市场占有率（按地区划分）

糖尿病视网膜病变是糖尿病併发症，会导致视网膜受损。糖尿病引起的高血糖值会损害视网膜内的血管。糖尿病视网膜病变发生在第 1 型和第 2 型糖尿病中，是工作年龄族群失明的主要原因。全球糖尿病视网膜病变市场的发展受到糖尿病盛行率上升、对糖尿病视网膜病变诊断和治疗认识的提高以及先进视网膜筛检技术的普及等因素的推动。然而，高昂的治疗费用和不佳的报销政策限制了市场的成长。

市场动态：

视网膜筛检、药物和手术的高成本、新兴国家眼科医生的短缺以及一些国家保险覆盖不足预计将抑制市场的成长。关键机会在于开发具有成本效益的筛检解决方案、联合疗法和人工智慧分析平台，以便更快、更准确地检测糖尿病视网膜病变。

本研究的主要特点

本报告对全球糖尿病视网膜病变市场进行了详细分析，并提供了预测期（2025-2032，以 2024 年为基准年）的市场规模和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球糖尿病视网膜病变市场的主要企业概况。

这项研究涉及的主要企业包括诺华公司、拜耳公司、再生元製药公司、罗氏控股公司、艾尔建公司、蔡司国际、托普康公司、海德堡工程有限公司、Optos PLC、佳能公司、尼德克有限公司、Ellex Medical Lasers Limited、博士伦公司、雅培实验室和参天製药株式会社。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球糖尿病视网膜病变市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 9.91 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 15.40 Bn

Diabetic retinopathy is a medical condition in which damage occurs to the retina due to complications of diabetes mellitus. High blood sugar levels associated with diabetes can damage blood vessels inside the retina. Diabetic retinopathy occurs in both type 1 and type 2 diabetes and is a leading cause of blindness among working-age adults. The global diabetic retinopathy market is driven by rising prevalence of diabetes, increasing awareness regarding diabetic retinopathy diagnosis and treatment, and the availability of advanced retinal screening techniques. However, high cost of treatment and inadequate reimbursement policies limit the market growth.

Market Dynamics:

High cost of retinal screening, drugs, and surgeries, shortage of ophthalmologists in developing nations, and inadequate insurance coverage in some countries are expected to restrain the market growth. Key opportunity lies in development of cost-effective screening solutions, combinational therapeutics, and artificial intelligence-powered analytic platforms to detect diabetic retinopathy faster and more accurately.

Key Features of the Study:

This report provides in-depth analysis of the global diabetic retinopathy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global diabetic retinopathy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Novartis AG, Bayer AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Allergan PLC, Zeiss International, Topcon Corporation, Heidelberg Engineering GmbH, Optos PLC, Canon Inc., Nidek Co., Ltd., Ellex Medical Lasers Limited, Bausch + Lomb Incorporated, Abbott Laboratories, and Santen Pharmaceutical Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global diabetic retinopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

By Disease Type Insights (Revenue, USD Bn, 2019 - 2032)
- Proliferative Diabetic Retinopathy
- Non-proliferative Diabetic Retinopathy
By Treatment Type Insights (Revenue, USD Bn, 2019 - 2032)
- Anti-Vascular Endothelial Growth Factor Therapy
- Intraocular Steroid Injection
- Laser Surgery
- Vitrectomy
- Others (Intraocular Corticosteroids, etc.)
By Route of Administration Insights (Revenue, USD Bn, 2019 - 2032)
- Intravitreal Injections
- Intravitreal Implants
- Oral
- Topical Eye Drops
- Laser Surgery
- Others
By End User Insights (Revenue, USD Bn, 2019 - 2032)
- Hospitals
- Ophthalmology Clinics
- Ambulatory Surgery Centers
- Long-Term Care Centers
- Others
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2019 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- Bayer AG
- Regeneron Pharmaceuticals Inc.
- Roche Holding AG
- Allergan PLC
- Zeiss International
- Topcon Corporation
- Heidelberg Engineering GmbH
- Optos PLC
- Canon Inc.
- Nidek Co., Ltd.
- Ellex Medical Lasers Limited
- Bausch + Lomb Incorporated
- Abbott Laboratories
- Santen Pharmaceutical Co., Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Diabetic Retinopathy Market, By Disease Type
- Global Diabetic Retinopathy Market, By Treatment Type
- Global Diabetic Retinopathy Market, By Route of Administration
- Global Diabetic Retinopathy Market, By End User
- Global Diabetic Retinopathy Market, By Distribution Channel
- Global Diabetic Retinopathy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Diabetic Retinopathy Market, By Disease Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Proliferative Diabetic Retinopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Non-proliferative Diabetic Retinopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Diabetic Retinopathy Market, By Treatment Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Anti-Vascular Endothelial Growth Factor Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intraocular Steroid Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laser Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Vitrectomy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Intraocular Corticosteroids, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Diabetic Retinopathy Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravitreal Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intravitreal Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Topical Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laser Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Diabetic Retinopathy Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ophthalmology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Long-Term Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Diabetic Retinopathy Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Diabetic Retinopathy Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
Regeneron Pharmaceuticals Inc.
Roche Holding AG
Allergan PLC
Zeiss International
Topcon Corporation
Heidelberg Engineering GmbH
Optos PLC
Canon Inc.
Nidek Co., Ltd.
Ellex Medical Lasers Limited
Bausch + Lomb Incorporated
Abbott Laboratories
Santen Pharmaceutical Co., Ltd.

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

糖尿病视网膜病变市场：依疾病类型、治疗类型、给药途径、最终用途、通路及地区划分